This patient-friendly article is about chemotherapy drug, Mitozantrone (Novantrone) which works similarly to Adriamycin, but has much less cardio-toxicity. It is therefore good for use with frailer patients with breast cancer, non-Hodgkin’s disease and lymphoma. It is also used in the treatment of prostate cancer. Is also sometimes referred to as Mitoxantrone.
Side effects may include: Lowered resistance to infection (but not as severe as with Adriamycin), bruising and bleeding, green/blue urine (because of the colour of the drug), nausea and vomiting, fatigue. Hair loss is rare, as are mouth sores, diarrhoea and temporary liver damage.
Go to: 10 ways to improve your chemotherapy success and reduce side-effects
Other articles that you may find interesting are:
- A diet for Chemotherapy
- Immunotherapy overview
- A to Z Guide to Complementary Therapies
Go to: Return to the CANCERactive drug list